HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term results of modified distal splenorenal shunts for the treatment of esophageal varices.

AbstractBACKGROUND/AIMS:
Long-term results were compared for 3 types of distal splenorenal shunt for the treatment of esophageal varices.
METHODOLOGY:
Between July 1983 and December 1997, 45 patients with esophageal varices underwent distal splenorenal shunt. Group 1 underwent standard distal splenorenal shunt (n = 11). Group 2 underwent distal splenorenal shunt with splenopancreatic disconnection (n = 11). Group 3 underwent distal splenorenal shunt with splenopancreatic disconnection and gastric transection (n = 23).
RESULTS:
Additional treatment for recurrent varices was required in group 1, (n = 1, 9.1%), group 2 (n = 2, 18.2%), and group 3 (n = 1, 4.3%). All of the patients with recurrent varices developed a shunt stenosis within the 1st year after distal splenorenal shunt. The prevalence of hyperammonemia in group 1 was 40.0% at 1, 5, and 10 years. In group 2, the prevalence was 14.3% at 1 year, 31.4% at 5 years, and 54.3% at 10 years. In group 3, the prevalence was 0% at 1 year, and 9.1% at 5 and 10 years. The differences between group 3 and groups 1 and 2 were significant (P < 0.01). The cumulative survival rates at 1 year were 90.9%, 63.6%, and 95.7% for groups 1, 2, and 3, respectively. At 10 years, the cumulative survivals rates were 70.7%, 63.6%, and 69.4% for groups 1, 2, and 3, respectively. There were no significant differences in survival between the 3 groups.
CONCLUSIONS:
Distal splenorenal shunt with splenopancreatic disconnection and gastric transection may reduce the incidence of postoperative hyperammonemia.
AuthorsT Tajiri, M Onda, H Yoshida, Y Mamada, N Taniai, M Umehara, M Toba, K Yamashita
JournalHepato-gastroenterology (Hepatogastroenterology) 2000 May-Jun Vol. 47 Issue 33 Pg. 720-3 ISSN: 0172-6390 [Print] Greece
PMID10919018 (Publication Type: Journal Article)
Topics
  • Adult
  • Esophageal and Gastric Varices (surgery)
  • Female
  • Humans
  • Hyperammonemia (prevention & control)
  • Male
  • Middle Aged
  • Portal System (diagnostic imaging)
  • Postoperative Complications (prevention & control)
  • Radiography
  • Splenorenal Shunt, Surgical (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: